Related Experiment Video
Updated: Nov 20, 2025

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
Published on: December 17, 2010
Idiopathic hypertrophic pachymeningitis with anticardiolipin antibody: A case report
Chi-Shun Wu1, Hung-Ping Wang2, Sheng-Feng Sung1
1Division of Neurology.
Rationale:
Idiopathic hypertrophic pachymeningitis (IHP) is a rare neurological disorder without a definite etiology. Diagnosis is mainly based on exclusion of other etiologies.
Patient Concerns:
A 41-year-old male patient presented with insidious onset headache of 3-month duration.
Diagnoses:
Contrast-enhanced brain magnetic resonance imaging (MRI) revealed diffuse pachymeningeal enhancement over bilateral cerebral hemispheres and the tentorium cerebelli. Lumbar puncture showed increased pressure, lymphocytic pleocytosis, and elevated protein level with normal glucose concentration. Blood tests detected elevated erythrocyte sedimentation rate (ESR) and C-reactive protein. Pathological examination of the dura mater from the right frontal convexity disclosed coarse collagenous deposition with focal lymphoid aggregation. After malignancy and infectious etiologies were excluded, a diagnosis of IHP was made.
Interventions:
Oral prednisolone and azathioprine followed by methotrexate were administered.
Outcomes:
During the 7-year follow-up period, although the patient was not totally headache-free, medical therapy significantly reduced the severity of headache. Follow-up MRI studies showed a reduction in meningeal enhancement and serial ESR measurements revealed a trend of improvement.
Lessons:
Methotrexate therapy may be considered in cases of steroid-resistant IHP. In addition to clinical evaluation, serial ESR testing may be considered to guide the treatment strategy and assess the response to therapy.
Insights
Idiopathic hypertrophic pachymeningitis (IHP) can be treated with methotrexate for steroid-resistant cases. Serial erythrocyte sedimentation rate (ESR) testing helps monitor treatment response in patients with this rare neurological disorder.
Area of Science:
- Neurology
- Pathology
Background:
- Idiopathic hypertrophic pachymeningitis (IHP) is a rare neurological condition with an unknown cause.
- Diagnosis relies on excluding other potential etiologies.
Observation:
- A 41-year-old male presented with a 3-month history of headache.
- MRI revealed diffuse pachymeningeal enhancement; lumbar puncture showed elevated pressure, lymphocytic pleocytosis, and protein.
- Blood tests indicated elevated ESR and C-reactive protein.
Findings:
- Pathology showed collagen deposition and lymphoid aggregation in the dura mater.
- After excluding malignancy and infection, IHP was diagnosed.
- Treatment with prednisolone, azathioprine, and methotrexate led to reduced headache severity and meningeal enhancement over 7 years.
Implications:
- Methotrexate is a potential therapy for steroid-resistant IHP.
- Serial ESR testing can guide treatment strategy and assess therapeutic response.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease I: Introduction
Pericarditis I: Introduction
Pericarditis II: Clinical Features and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction

